US Patent 9399017 Peptide pharmaceutical for oral delivery
Patent 9399017 was granted and assigned to Enteris Biopharma, Inc. on July, 2016 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 9399017 Peptide pharmaceutical for oral delivery
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.